NasdaqGS - Delayed Quote USD
Upstream Bio, Inc. (UPB)
8.82
-0.02
(-0.23%)
At close: May 9 at 4:00:01 PM EDT
8.82
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AI UPSTREAM LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| CHIMOVITS EREZ Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 15, 2024 | -- |
| WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN II Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Oct 15, 2024 | 894,733 |
Related Tickers
MBX MBX Biosciences, Inc.
11.11
-5.12%
ZBIO Zenas BioPharma, Inc.
9.05
-2.58%
SYRE Spyre Therapeutics, Inc.
14.10
+9.64%
ABVX ABIVAX Société Anonyme
6.71
-2.04%
SEPN Septerna, Inc.
6.69
-3.74%
TRML Tourmaline Bio, Inc.
15.10
-4.07%
AARD Aardvark Therapeutics, Inc.
10.42
-2.89%
SION Sionna Therapeutics, Inc.
12.32
-1.99%
INVA Innoviva, Inc.
18.56
-0.11%
APGE Apogee Therapeutics, Inc.
37.29
-1.38%